Ascend Wellness Holdings (AAWH) Retained Earnings (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Retained Earnings came in at $471.2 million in Q1 2026, little changed year-on-year from $471.3 million in Q1 2025, and little changed quarter-over-quarter from $470.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Retained Earnings (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $471.2 million for Q1 2026.
- On a quarterly basis, Retained Earnings changed 0.01% year-over-year to $471.2 million in Q1 2026; TTM through Mar 2026 was $471.2 million, a 0.01% change from a year earlier, with the FY2025 full-year figure at $470.9 million, changed 0.05% from the prior year.
- Retained Earnings was little changed at $471.2 million in Q1 2026 per AAWH's latest filing, from $470.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $471.4 million in Q3 2025 and bottomed at -$383.6 million in Q3 2024.
- The 5-year median for Retained Earnings is $450.5 million (2023), against an average of $147.1 million.
- Across the five-year window, Retained Earnings jumped 432.62% in 2022 and plunged 178.86% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$267.1 million in 2022, then jumped by 271.45% to $458.0 million in 2023, then gained by 2.86% to $471.1 million in 2024, then fell by 0.05% to $470.9 million in 2025, then climbed by 0.07% to $471.2 million in 2026.
- Per Business Quant, the three latest AAWH Retained Earnings figures stand at $471.2 million (Q1 2026), $470.9 million (Q4 2025), and $471.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 471.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 471.25 Mn |
| Dec 31, 2025 | 470.91 Mn |
| Sep 30, 2025 | 471.40 Mn |
| Jun 30, 2025 | 471.15 Mn |
| Mar 31, 2025 | 471.29 Mn |
| Dec 31, 2024 | 471.13 Mn |
| Sep 30, 2024 | -383.57 Mn |
| Jun 30, 2024 | -355.31 Mn |
| Mar 31, 2024 | 468.09 Mn |
| Dec 31, 2023 | 458.03 Mn |
| Sep 30, 2023 | -296.02 Mn |
| Jun 30, 2023 | 450.53 Mn |
| Mar 31, 2023 | -285.62 Mn |
| Dec 31, 2022 | -267.15 Mn |
| Sep 30, 2022 | -252.10 Mn |
| Jun 30, 2022 | -235.24 Mn |
| Mar 31, 2022 | 371.92 Mn |
| Dec 31, 2021 | 362.56 Mn |
| Sep 30, 2021 | -169.74 Mn |
| Jun 30, 2021 | -156.71 Mn |